TDC
ISEE

Thompson Davis & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Thompson Davis & Co’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$19K Hold
7,843
– – 0.04% 345
2018
Q2 		$21K Sell
7,843
-8,195
-51% -$22.6K 0.05% 306
2018
Q1 		$44K Buy
16,038
+7,813
+95% +$22.6K 0.12% 185
2017
Q4 		$26K Buy
+8,225
New +$23.1K 0.06% 280
2014
Q2 		– Sell
-500
Closed -$18K – 874
2014
Q1 		$18K Buy
+500
New +$16.9K 0.03% 404

Other funds holding ISEE

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Thompson Davis & Co's ISEE Position: Q3 2018 in Review

Thompson Davis & Co held its IVERIC bio, Inc. Common Stock (ISEE) position steady in Q3 2018 at 7,843 shares worth $19K. The position accounts for 0.04% of the portfolio, ranked #345.

Thompson Davis & Co first reported a position in ISEE in Q1 2014 and has held it in 5 quarters since. The position peaked at $44K in Q1 2018. 68 funds tracked by Wall St. Rank hold ISEE as of Q3 2018.

  • Thompson Davis & Co held 7,843 shares of IVERIC bio, Inc. Common Stock worth $19K as of Q3 2018.
  • Thompson Davis & Co left its IVERIC bio, Inc. Common Stock share count unchanged in Q3 2018.
  • IVERIC bio, Inc. Common Stock made up 0.04% of Thompson Davis & Co's portfolio in Q3 2018, its #345 holding.
  • Thompson Davis & Co first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and has held it in 5 quarters since.
  • Thompson Davis & Co's IVERIC bio, Inc. Common Stock position peaked at $44K in Q1 2018.
  • 68 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.